Ever wondered why so many people are skipping the big-name weight-loss drugs? Turns out, about 1.5 million Americans are turning to cheaper, copycat versions of popular obesity meds because the originals are just too pricey. Novo Nordisk, the company behind Wegovy, is now hustling to offer more affordable options. The takeaway? When prices get too high, people find workarounds—even if it means a little risk. Always double-check what you’re buying online! #Business #Industry #healthhacks